Nancy Lynn Snyderman M.D., Director at Alkermes plc. (ALKS), sold 44,472 shares at $50.35 ($2.2M) on 2026-08-03, disclosed to the SEC on 2026-08-03.
Open-market sale of $2.2M ALKS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AXNX | BUY | 2019-07-01 | $74K | — | Filing → |